The Impact of Switching to a Second Antifibrotic Therapy on Outcomes in Patients With IPF in the Empire Registry Treated With Pirfenidone or Nintedanib
暂无分享,去创建一个
M. Žurková | M. Doubková | N. Mogulkoc | K. Lewandowska | M. Vašáková | L. Lacina | P. Ovesná | M. Plačková | V. Müller | M. Studnicka | J. Gregor | V. Bartoš | M. Kramer